# Reduced vs Conventional Dosage Intensity-modulated Radiotherapy for Chemotherapy-sensitive Stage II-III Nasopharyngeal Carcinoma

> **NCT04448522** · PHASE3 · RECRUITING · sponsor: **Sun Yat-sen University** · enrollment: 508 (estimated)

## Conditions studied

- Nasopharyngeal Carcinoma
- Radiotherapy
- Chemotherapy

## Interventions

- **RADIATION:** reduced dosage IMRT
- **RADIATION:** conventional dosage IMRT

## Key facts

- **NCT ID:** NCT04448522
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-08-18
- **Primary completion:** 2026-08
- **Final completion:** 2028-08
- **Target enrollment:** 508 (ESTIMATED)
- **Last updated:** 2020-09-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04448522

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04448522, "Reduced vs Conventional Dosage Intensity-modulated Radiotherapy for Chemotherapy-sensitive Stage II-III Nasopharyngeal Carcinoma". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT04448522. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*